Use of in vitro drug metabolism data to evaluate metabolic drug-drug interactions in man: the need for quantitative databases.
- 1 April 2001
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 41 (4) , 368-373
- https://doi.org/10.1177/00912700122010212
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Assessment of the Quality and Quantity of Drug‐Drug Interaction Studies in Recent NDA Submissions: Study Design and Data Analysis IssuesThe Journal of Clinical Pharmacology, 1999
- FDA Evaluations Using In Vitro Metabolism to Predict and Interpret In Vivo Metabolic Drug‐Drug Interactions: Impact on LabelingThe Journal of Clinical Pharmacology, 1999
- Preclinical andin vitroassessment of the potential of D0870, an antifungal agent, for producing clinical drug interactionsXenobiotica, 1999
- In vitro assessment of human cytochrome P450Xenobiotica, 1998
- An Evaluation of the Integration of Pharmacokinetic and Pharmacodynamic Principles in Clinical Drug DevelopmentClinical Pharmacokinetics, 1997
- Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic InteractionsClinical Pharmacokinetics, 1997
- Clinical Pharmacokinetics and Pharmacodynamics of ZolpidemClinical Pharmacokinetics, 1995
- ZolpidemDrugs, 1990
- Pharmacokinetics of the Newer BenzodiazepinesClinical Pharmacokinetics, 1989
- Kinetics of drug-drug interactionsJournal of Pharmacokinetics and Biopharmaceutics, 1973